5-HT(1a) and 5-HT(2A) ligands with anxiolytic and antipanic-like properties

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 20, 1997, Pages 2579-2584

  Diouf, O ^a   Carato, P ^a   Depreux, P ^a   Bonte, J P ^a   Caignard, D H ^b   Guardiola Lemaitre B ^b   Rettori, M C ^b   Belzung, C ^b   Lesieur, Daniel ^a  

^a Institut de Chimie Pharmaceutique   (France)

^b ADIR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZOXAZOLONE DERIVATIVE; ALPHA 1 ADRENERGIC RECEPTOR; BENZOTHIAZOLINE DERIVATIVE; BENZOXAZINONE DERIVATIVE; DOPAMINE 2 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1C RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HEAD TWITCH; MOUSE; NONHUMAN; REACTION ANALYSIS; RECEPTOR AFFINITY;

EID: 0030693259     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)10023-3     Document Type: Article

References (24)

1. Traber, J.; Glaser, T. Trends Pharmacol. Sci. 1987, 8, 432-437.
2. Glitz, D.A.; Pohl, R. Drugs, 1991, 41, 11-18.
3. Goldberg, H.L.; Finnerty, R. J. Clin. Psychiatry 1982, 43, 87-91.
4. Munjack, D.J.; Bruns, J.; Baltazar, P.L.; Brown, R. J. Anxiety Disord. 1991, 5, 87-98.
5. Glennon, R.A.S. Neurosci. Biobehav. Rev., 1990,14, 35-47.
6. Peroutka, S.J. Ed. Serotonin Receptor Subtypes. Basic and Clinical Aspects; Ed.Wiley-Liss: New York, 1991, 211-227.
7. Wilkstrom, H.; Svensson, K. Ann. Rep. Med. Chem. 1989, 25, 41-50.
8. Bockaert, J.; Dumuis, A.; Bouhelal, R.; Sebben, M.; Cory, R. Nauny Schmiedebergs Arch. Pharm. 1987, 335, 588-592.
9. Arriaga, F.; Leitao, J.; Padua, J.; Ruiz, I.; Tropa, J.; Sousa, M.P.; Mills, F.J.; Gelders, Y. C.I.P.N., Congress Puerto Rico 1986, 174.
10. Da Roza Davis, J.M.; Scharpley, A.L.; Cowen, P.J. Psychopharmacol. 1992, 108, 387-389.
11. Albinsson, A.; Björk, A.; Svartengren, J.; Klint, T.; Andersson G. Eur. J. Pharmacol. 1994, 261, 285-294.
12. 1C/2 antagonists, potential anxiolytic agents. In: Hamon, M.; Ollat, H.; Thiebot, M.H., eds. Anxiety: Neurobiology, clinic and therapeutic perspectives. Paris: Les éditions INSERM/John Libbey Eurotext: 1993: 153-164.
13. Taverne, T.; Lesieur, I.; Depreux, D.; Caignard, D.H.; Guardiola, B. Eur. Pat. (1991) 4025465; Chem. Abstr. (1992), 117, 69855j.
14. Taverne, T.; Lesieur, I.; Depreux, D.; Caignard, D.H.; Guardiola, B. Eur. Pat. (1991) 4025465; Chem. Abstr. (1992), 117, 69855j.
15. Lowe, J.A.; Seeger, T.F.; Nagel, A.A.; Howard, H.R.; Seymour, P.A.; Heym, J.H.; Ewing, F.E.; Newman, M.E.; Schmidt, A.W.; Furman, J.S.; Vincent, L.A.; Maloney, P.R.; Robinson, G.L.; Reynolds, L.S.; Vinick, F.J. J. Med. Chem. 1991, 34, 1860-1866.
16. Glennon, R.A.; Naiman, R.A.; Lyon, R.A.; Titeler, M. J. Med. Chem. 1988, 31, 1968-1971.
17. Mokrosz, J.L.; Strekowski, L.; Duszyuska, D.; Harden, D.B.; Mokrosz, M.J.; Bojarski, Pharmazie 1994, 49, 801-806.
18. Diouf, O.; Depreux, P.; Lesieur, D.; Guardiola, B.; Caignard, D.; Adam, G. Fr. Pat. (1993) 02528.
19. Griebel, G.; Blanchard, D.C.; Rettori, M.C.; Guardiola-Lemaître, B.; Blanchard, R.J. Pharmacol. Biochem. Behav. 1996, 54, 509-516.
20. Yous, S.; Poupaert, J.H.; Lesieur, I.; Depreux, P.; Lesieur, D. J. Org. Chem. 1994, 59, 1574-1576.
21. Diouf, O.; Depreux, P.; Lesieur, D.; Poupaert, J.H.; Caignard, D.H. Eur. J. Med. Chem.. 1995, 30, 715-719.
22. Diouf, O.; Depreux, P.; Lesieur, D.; Poupaert, J.H.; Caignard, D.H. Heterocycles 1995, 41, 1219-1233.
23. Moussavi, Z.; Depreux, P.; Lesieur, I.; Sauzières, J. Heterocycles 1991, 32, 2119-2125.
24. Poupaert, J.H.; Kanyonyo, M.D ; Ucar, H. ; Mouithys, A.M. ; Diouf, O.; Lesieur, D. Bull. Soc. Chim. Belg. 1996, 105 (7), 397-401.